Atlas Trials

Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care

Clinical trial NCT02320084 · COMPLETED

Trial details

NCT number
NCT02320084
Sponsor
Swedish Orphan Biovitrum
Status
COMPLETED
Study type
OBSERVATIONAL
Hereditary Tyrosinemia, Type I
Start date
2013-09-01
Primary completion
2019-09-30
Enrollment
315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.